Ocular Motor Cranial Nerve Palsy as an Indicator of Neglected Systemic Disease in Nigeria: Perspective from a Neuro-Ophthalmology Clinic

References

• Sitaula S, Sharma A, Shrestha GG, Gajurel BP, Shrestha G. Clinical manifestation of ocular motor nerve palsies in a tertiary eye hospital of Kathmandu, Nepal. J Inst Med. 2014;36:72–77.
   Google Scholar
• Rowe F. UK VIS research group. Prevalence of ocular motor cranial nerve palsy and associations following stroke. Eye (Lond). 2011;25(7):881–887. doi:10.1038/eye.2011.78.
   PubMed Web of Science ®Google Scholar
• Lyons CJ, Godoy F, Al Qahtani E. Cranial nerve palsies in childhood. Eye (Lond). 2015;29(2):246–251. doi:10.1038/eye.2014.292.
   PubMed Web of Science ®Google Scholar
• Berlit P. Isolated and combined pareses of cranial nerves III, IV and VI. A retrospective study of 412 patients. J Neurol Sci. 1991;103:10–15.
   PubMed Web of Science ®Google Scholar
• Galtrey CM, Schon F, Nitkunan A. Microvascular non-arteritic ocular motor nerve palsies-what we know and how should we treat? Neuroophthalmology. 2015;39(1):1–11. doi:10.3109/01658107.2014.963252.
   PubMed Web of Science ®Google Scholar
• Mwanza J, Ngweme G, Kayembe D. Ocular motor nerve palsy: A clinical and etiological study. Indian J Ophthalmol. 2006;54(3):173–175. doi:10.4103/0301-4738.27068.
   PubMedGoogle Scholar
• Khadse R, Pawar N, Padmavathy SR, Ramakrishanan MR. Clinical profile of ocular motor nerve palsies at a tertiary centre in southern India. EC Ophthalmol. 2017;6:89–94.
   Google Scholar
• Kung NH, Van Stavern GP. Isolated ocular motor nerve palsies. Semin Neurol. 2015;35(5):539–548. doi:10.1055/s-0035-1563568.
   PubMed Web of Science ®Google Scholar
• Murchison AP, Gilbert ME, Savino PJ. Neuroimaging and acute ocular motor mononeuropathies: a prospective study. Arch Ophthalmol. 2011;129(3):301–305. doi:10.1001/archophthalmol.2011.25.
   PubMedGoogle Scholar
• Park UC, Kim SJ, Hwang JM, Yu YS. Clinical features and natural history of acquired third, fourth, and sixth cranial nerve palsy. Eye (Lond). 2008;22(5):691–696. doi:10.1038/sj.eye.6702720.
   PubMed Web of Science ®Google Scholar
• Richards BW, Jones FR Jr., Younge BR. Causes and prognosis in 4,278 cases of paralysis of the oculomotor, trochlear, and abducens cranial nerves. Am J Ophthalmol. 1992;113:489–496.
   PubMed Web of Science ®Google Scholar
• Surachatkumtonekul T, Soontrapa P, Kampanartsanya-korn S, Dulayajinda D. Causes and treatment outcomes of third, fourth and sixth cranial nerve palsy. J Med Assoc Thai. 2012;95:S96–S101.
   PubMedGoogle Scholar
• Tamhankar MA, Biousse V, Ying GS, et al. Isolated third, fourth, and sixth cranial nerve palsies from presumed microvascular versus other causes: a prospective study. Ophthalmology. 2013;120(11):2264–2269. doi:10.1016/j.ophtha.2013.04.009.
   PubMed Web of Science ®Google Scholar
• Tiffin PAC, Macewen CJ, Craig EA, Clayton G. Acquired palsy of the oculomotor, trochlear and abducens nerves. Eye. 1996;10(Pt 3):377–384. doi:10.1038/eye.1996.77.
   PubMedGoogle Scholar
• Pedro-Egbe CN, Fiebai B, Awoyesuku EA. A 3-year review of cranial nerve palsies from the University of Port Harcourt Teaching Hospital Eye Clinic, Nigeria. Middle East Afr J Ophthalmol. 2014;21(2):170–174. doi:10.4103/0974-9233.129770.
   PubMedGoogle Scholar
• Dreyfus PM, Hakim S, Adams RD. Diabetic ophthalmoplegia; report of case, with postmortem study and comments on vascular supply of human oculomotor nerve. AMA Arch Neurol Psychiatry. 1957;77:337–349.
   PubMedGoogle Scholar
• Sharpe JA, Wong AM, Fouladvand M. Ocular motor nerve palsies: implications for diagnosis and mechanisms of repair. Prog Brain Res. 2008;171:59–66. doi:10.1016/S0079-6123(08)00609-2.
   PubMed Web of Science ®Google Scholar
• Chou KL, Galetta SL, Liu GT, Volpe NJ, Bennett JL, Asbury AK, Balcer LJ. Acute ocular motor mononeuropathies: prospective study of the roles of neuroimaging and clinical assessment. J Neurol Sci. 2004;219(1):35–39. doi:10.1016/j.jns.2003.12.003.
   PubMed Web of Science ®Google Scholar
• Shakya S, Argrawal JP, Ray P. Profile of isolated sixth cranial nerve palsy: a hospital based study. J Neurosci. 2004;1:32–35.
   Google Scholar
• Ajayi I, Sowemimo I, Akpa O, Ossai N. Prevalence of hypertension and associated factors among residents of Ibadan-north local government area of Nigeria. Niger J Cardiol. 2016;13(1):67–75. doi:10.4103/0189-7969.165168.
   Google Scholar
• Howard G, Lackland DT, Kleindorfer DO, Kissela BM, Moy CS, Judd SE, Safford MM, Cushman M, Glasser SP, Howard VJ. Racial differences in the impact of elevated systolic blood pressure on stroke risk. JAMA Intern Med. 2013;173(1):46–51. doi:10.1001/2013.jamainternmed.857.
   PubMed Web of Science ®Google Scholar
• Akinlua JT, Meakin R, Umar AM, Freemantle N. Current prevalence pattern of hypertension in Nigeria: A systematic review. PLoS ONE. 2015;10(10):e0140021. doi:10.1371/journal. pone.0140021 (Electronic).
   Google Scholar
• Oguoma VM, Nwose EU, Skinner TC, Digban KA, Onyia IC, Richards RS. Prevalence of cardiovascular disease risk factors among a Nigerian adult population: relationship with income level and accessibility to CVD risks screening. BMC Public Health. 2015;15:397. doi:10.1186/s12889-015-1709-2.
   PubMed Web of Science ®Google Scholar
• Isara AR, Okundia PO. The burden of hypertension and diabetes mellitus in rural communities in southern Nigeria. Pan Afr Med J. 2015;20:103. doi:10.11604/pamj.2015.20.103.5619.
   PubMed Web of Science ®Google Scholar
• Capó H, Warren F, Kupersmith MJ. Evolution of oculomotor nerve palsies. J Clin Neuroophthalmol. Mar 1992;12(1):21–25.
   PubMedGoogle Scholar
• Comer RM, Dawson E, Plant G, Acheson JF, Lee JP. Causes and outcomes for patients presenting with diplopia to an eye casualty department. Eye. 2007;21:413–418. doi:10.1038/sj.eye.6702415.
   PubMed Web of Science ®Google Scholar
• Olakunde B. Public health care financing in Nigeria: which way forward? Ann Niger Med. 2012;6(1):4–10. doi:10.4103/0331-3131.100199.
   Google Scholar
• Lagarde M. The impact of user fees on health service utilization in low- and middle-income countries: how strong is the evidence? Bull World Health Organ. 2008;86:839–848.
   PubMed Web of Science ®Google Scholar
• Awosusi A, Folaranmi T, Yates R. Nigeria’s new government and public financing for universal health coverage. Lancet Global Health. 2015;3(9): e514-e515. doi:10.1016/S2214-109X(15)00088-1.
   PubMed Web of Science ®Google Scholar
• Ogun OA, Adediran OA. Non-glaucomatous optic neuropathy in Ibadan: extrapolations to healthcare funding in Nigeria. Ann Ibd Pg Med. 2014;12:103–108.
   Google Scholar
• National Health Insurance Scheme. National health insurance scheme: scope of coverage. 2018. https://www.nhis.gov.ng. Accessed July 5, 2018.
   Google Scholar